ANTITHROMBIN-III AND HEPARIN

被引：0
作者：
不详
机构：
来源：
LANCET | 1978年 / 1卷 / 8063期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：538 / 539
页数：2
相关论文
共 12 条
[1]   PROSPECTIVE STUDY OF VALUE OF MONITORING HEPARIN TREATMENT WITH ACTIVATED PARTIAL THROMBOPLASTIN TIME [J].
BASU, D ;
CADE, J ;
GALLUS, A ;
HIRSH, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (07) :324-+
[2]   ANTITHROMBIN-III, ANTIFACTOR-XA AND HEPARIN [J].
BIGGS, R ;
DENSON, KWE ;
AKMAN, N ;
BORRETT, R ;
HADDEN, M .
BRITISH JOURNAL OF HAEMATOLOGY, 1970, 19 (03) :283-&
[3]   METABOLISM OF ANTITHROMBIN-3 (HEPARIN COFACTOR) IN MAN - EFFECTS OF VENOUS THROMBOSIS AND OF HEPARIN ADMINISTRATION [J].
COLLEN, D ;
SCHETZ, J ;
DECOCK, F ;
HOLMER, E ;
VERSTRAETE, M .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1977, 7 (01) :27-35
[4]  
DENSON KWE, 1977, LANCET, V2, P1028
[5]  
MANT MJ, 1977, LANCET, V1, P1133
[6]  
MARCINIAK E, 1977, LANCET, V2, P581
[7]  
OBRIEN JR, 1977, LANCET, V2, P1232
[8]  
ROSENBERG RD, 1975, NEW ENGL J MED, V292, P146
[9]   MANAGEMENT OF HEPARIN THERAPY - CONTROLLED PROSPECTIVE TRIAL [J].
SALZMAN, EW ;
DEYKIN, D ;
SHAPIRO, RM ;
ROSENBERG, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (20) :1046-1050
[10]  
THOMAS DP, 1978, SEMIN HEMATOL, V15, P1
12